• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Updates, 04-08-2026: Press Release (Revised)

    04-08-2026 | 02:51 pm

    Alembic Pharma reported strong Q1 FY27 results: Revenue up 26% to Rs 2150 Cr, PAT up 12% to Rs 173 Cr. Growth was broad-based, with US Formulation up 49% and API up 33%. New launches and ANDA approvals drove performance. An investor call is scheduled.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited